Drug Profile
Research programme: biodefence vaccines - Crucell/Naval Medical Research Center
Alternative Names: Biodefense vaccines - Crucell/Naval Medical Research CenterLatest Information Update: 16 Jun 2011
Price :
$50
*
At a glance
- Originator Crucell; Naval Medical Research Center
- Developer Naval Medical Research Center
- Class Anthrax vaccines; Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anthrax; Yersinia infections
Most Recent Events
- 06 Mar 2008 Preclinical development is ongoing
- 07 Aug 2007 Ichor Medical Systems partners with the Naval Medical Research Center to assess Ichor's TriGrid™ Delivery System in the development of a DNA vaccine for anthrax and plague
- 01 Sep 2005 Preclinical trials in Anthrax in Netherlands (unspecified route)